Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Centene Corp.
CNC
NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $33.7B
$67.29
▼ -1.55%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$25.08 - $69.29
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 102.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive Government Program Expertise
- Diversified Healthcare Service Portfolio
- Strong Geographic Market Presence
- Cost-Efficient Healthcare Delivery Model
Bear Case
2 risks
- Average volatility.
- Premium valuation to Managed Care & Health Insurance peers
Growth
Turning profitable
Expanding Medicaid Enrollment
Value
Premium valuation to Managed Care & Health Insurance peers
Momentum
Hot
+94.7% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CNC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 23, 2026
APR 28, 2026
Reported EPS of $3.37 vs $2.23 consensus (+51.1% surprise). Revenue of $49.9B vs $47.5B expected (+5.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+51.1%
Next: Apr 23, 2026
Revenue trend · last 8Q
—
—
+3%
+15%
+22%
+18%
+22%
+7%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$39.8B
$42.0B
$40.8B
$46.6B
$48.7B
$49.7B
$49.7B
$49.9B
Margins · last 8Q
Gross
21.9%
Operating
3.7%
Profit
3.1%
Wall Street consensus
16 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
44%
Sell
6%
Median Price Target
$60.00
▼ -10.8% vs $67.29
Latest: RBC Capital · Jun 23, 2026
10 analysts covering